We have collected information about Nanovector Delivery Of Sirna For Cancer Therapy for you. Follow the links to find out details on Nanovector Delivery Of Sirna For Cancer Therapy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842228/
Nanotechnology has played an important role in siRNA cancer therapy, and many nanovector strategies have been developed for siRNA delivery. Current nanovectors can be divided into three groups: lipid-based, non-lipid organic-based, and inorganic (Table 1).Author: Haifa Shen, T. Sun, Mauro Ferrari
https://www.nature.com/articles/cgt201222
Nanotechnology has had an important role in siRNA cancer therapy, and many nanovector strategies have been developed for siRNA delivery. Current nanovectors …Author: Haifa Shen, T. Sun, Mauro Ferrari
https://www.ncbi.nlm.nih.gov/pubmed/22555511
RNA interference holds the promise to knock down expression of every cancer gene. Both academic laboratories and pharmaceutical companies have committed heavily on manpower and financial resources to develop small interfering RNA (siRNA) cancer therapeutics over the last decade.Author: Haifa Shen, T. Sun, Mauro Ferrari
http://europepmc.org/articles/PMC3842228
Jun 01, 2012 · Nanotechnology has played an important role in siRNA cancer therapy, and many nanovector strategies have been developed for siRNA delivery. Current nanovectors can be divided into three groups: lipid-based, non-lipid organic-based, and inorganic (Table 1).
https://www.researchgate.net/publication/224896818_Nanovector_Delivery_of_siRNA_for_Cancer_Therapy
Request PDF Nanovector Delivery of siRNA for Cancer Therapy RNA interference holds the promise to knock down expression of every cancer gene.
https://scholars.houstonmethodist.org/en/publications/nanovector-delivery-of-sirna-for-cancer-therapy(dfd566e0-cd5a-4a3a-9f0e-818bd16c760e).html
title = "Nanovector delivery of siRNA for cancer therapy", abstract = "RNA interference holds the promise to knock down expression of every cancer gene. Both academic laboratories and pharmaceutical companies have committed heavily on manpower and financial resources to develop small interfering RNA (siRNA) cancer therapeutics over the last decade.Author: Haifa Shen, T. Sun, Mauro Ferrari
https://www.sciencedirect.com/science/article/pii/S0142961210008574
Efficient and specific delivery of siRNA to target cancer cells continues to be the major hurdle to application of siRNA for cancer therapy. Nanovectors, when properly engineered, can be used to overcome these hurdles.Author: Omid Veiseh, Forrest M. Kievit, Chen Fang, Ni Mu, Soumen Jana, Matthew C. Leung, Hyejung Mok, Richar...
https://www.sciencedirect.com/science/article/pii/S1818087614000646
The currently developed siRNA delivery systems for cancer therapy can be divided into four categories: chemical modifications, lipid-based nanovectors, polymer-mediated delivery systems, conjugate delivery systems, and others (exosomes, RNAi-microsponges, oligonucleotide nanoparticles).Author: Cong-fei Xu, Jun Wang
https://www.nature.com/articles/nmat3765
Oct 23, 2013 · Therapeutics based on small interfering RNA (siRNA), which in principle are able to reversibly silence any gene of interest, are under development for the treatment …Author: Rosemary Kanasty, Joseph Robert Dorkin, Arturo Vegas, Arturo Vegas, Daniel Anderson
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009470/
Barriers of In vivo miRNA delivery for cancer therapy. The leaky structure and compression of abnormal tumor vessels lead to poor blood perfusion, which reduces the delivery efficacy of naked miRNAs. Extravascular miRNAs encounter the ECM, which blocks ...Author: Yunching Chen, Dong Yu Gao, Leaf Huang
Searching for Nanovector Delivery Of Sirna For Cancer Therapy?
You can just click the links above. The data is collected for you.
